Fri, Feb 27, 2015, 12:05 AM EST - U.S. Markets open in 9 hrs 25 mins


% | $
Quotes you view appear here for quick access.

Seattle Genetics Inc. Message Board

  • biogynecologist biogynecologist Nov 7, 2012 6:30 PM Flag

    After hours

    Why down so much in AH? All in all, I don't think the CC was bad. Just my honest opinion.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Disappointing top-line revenues and terrible 2013 guidance of flat sales. Analyst estimates have to come down for 2013 product sales.
      Management reiterates one day in the future it will be a big drug. That one day ain't gonne happen anytime soon.

      • 1 Reply to biotech_sage
      • I agree with the comments thus far.

        Paladin: Yes, I did hear the rather sudden switch from "billion" to "multi-billion," which I believe was uttered twice near the end. Siegall has gotten better at these things, but he still has a tendency to become tongue tied or lost in the weeds. He needs more consistent clarity, a more linear approach. Also, talking about getting lost in the weeds, a new side effect of Adcetris might be induced coma from listening to that marketing guy - yes, I agree with you there, too.

        Biotech: I was thinking the same thing -- given the time frames involved in this market sector, we are looking at another looooonnng wait before Adcetris revenues grow robustly and/or new products come on line. So, we're back to being very long-term investors with only one real hope for swift pps appreciation -- the takeover, which I still think is inevitable, maybe tomorrow, maybe a year from tomorrow, but one day fersure, and at a very high premium.

36.43-0.20(-0.55%)Feb 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.